Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(510)
•••
Comment by 2b7f6fabon Jul 10, 2017 9:02pm
191 Views
Post# 26453445

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lonade could not have said it better

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lonade could not have said it betterAs others have indicated, there is no present standard of care for NMIBC where scraping and bcg isn't working.  Hence no ph3 trial required.  You'd take it in a heart beat and you know it.


bionicjoe wrote:
2b7f6fab wrote: BJ would sing a different tune if he were diagnosed with bladder cancer.
coalbet wrote: I think death is a little harsh but you should be locked up.
Image result for jail funny images

 


If I were to be diagnosed with any type of cancer, not just bladder cancer I would listen to my specialist and begin whatever was the standard of care treatment for that particular form of the disease. I can assure you I would not be listening to a bunch of self interest profiteers on a message board play games with my life by making me their guinea pig in an experimental and unproven treatment. When a person is sick with cancer assurances from the arm chair quarterbacks mean squat.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities